Regardless of the potential mechanisms, which extend beyond the scope of this study, our results suggest that VDR (together with CD44) may serve as a valuable diagnostic marker for the HGSC type of ovarian cancer. This evidence concerns the gene CD44 and ovarian carcinoma.